All
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Report an inappropriate content
Please select one of the options below.
Not Relevant
Offensive
Adult
Child Sexual Abuse
Length
All
Short (less than 5 minutes)
Medium (5-20 minutes)
Long (more than 20 minutes)
Date
All
Past 24 hours
Past week
Past month
Past year
Resolution
All
Lower than 360p
360p or higher
480p or higher
720p or higher
1080p or higher
Source
All
Dailymotion
Vimeo
Metacafe
Hulu
VEVO
Myspace
MTV
CBS
Fox
CNN
MSN
Price
All
Free
Paid
Clear filters
SafeSearch:
Moderate
Strict
Moderate (default)
Off
Filter
Autoimmunity and Limitations of Cancer Vaccines
Aug 20, 2014
targetedonc.com
BPDCN: Epidemiology, Pathophysiology, and Diagnosis
Sep 27, 2022
targetedonc.com
Case 1: Newly Diagnosed CLL, IGHV-Unmutated
Jan 28, 2020
targetedonc.com
Identifying Patients With R/R MM Who Should Receive CAR T-Cell T
…
Oct 18, 2022
targetedonc.com
An Overview of BCG-Unresponsive Non-Muscle-Invasive Bladder Can
…
Nov 30, 2023
targetedonc.com
An Introduction to Front-line Nivolumab/Ipilimumab Therapy fo
…
1 month ago
targetedonc.com
Future Perspectives on the Relapsed/Refractory Follicular Ly
…
2 weeks ago
targetedonc.com
BCL-2 Inhibitors in AML: Treatment Considerations
Dec 23, 2019
targetedonc.com
Key Updates from ARMANI in Advanced HER2- Gastric/GEJ Can
…
7 months ago
targetedonc.com
SABCS 2020 Updates: ExteNET and CONTROL Trials
Jan 29, 2021
targetedonc.com
5:30
EMERALD Subgroup Analysis in HER2-Low Metastatic Breast Canc
…
Dec 8, 2023
targetedonc.com
Scenario 2: Ibrutinib and Ruxolitinib as Treatment Options in cGVHD
Apr 4, 2022
targetedonc.com
The Targeted Pulse: Discover the FDA’s Holiday Moves For Solid Tu
…
1 month ago
targetedonc.com
Upcoming Insights – Strategies for Management of Dermatological R
…
3 weeks ago
targetedonc.com
Targeted Therapies and Immunotherapy Play Greater Rol
…
Feb 27, 2023
targetedonc.com
Real-World (RW) Observations from CAR T in R/R Myeloma
1 week ago
targetedonc.com
BrECADD Shows Promise as New Standard for Advanced Hodgkin L
…
8 months ago
targetedonc.com
INAVO120: Inavolisib Combination Therapy in PIK3CA-Mutated Breas
…
7 months ago
targetedonc.com
Phase 3 NATALEE Study Assesses Ribociclib Plus ET in Early Breast
…
Jul 1, 2023
targetedonc.com
Newly Diagnosed mHSPC: First-Line Treatment Options
1 month ago
targetedonc.com
Yocum Discusses Updated Data From the Beat AML Master Trial
Jan 13, 2024
targetedonc.com
ESMO 2024: Updates in NIAGARA Study
4 months ago
targetedonc.com
Treatment Options for HR /HER2- Metastatic Breast Cancer with Dis
…
Mar 22, 2023
targetedonc.com
Advancements in AML Treatment in the Past 10 Years
5 months ago
targetedonc.com
Reviewing the Options for Bladder Cancer in Different Settings
4 weeks ago
targetedonc.com
TRANSCEND 004: Highlights from ASH 2024
3 weeks ago
targetedonc.com
Frontline Therapy for R/R DLBCL: TAFA/LEN/R-CHOP
Nov 24, 2021
targetedonc.com
Acalabrutinib May Be an Alternative to Ibrutinib For Treatment of CLL
Jan 7, 2020
targetedonc.com
Transitioning from ESAs to EMAs in MDS Treatment
5 months ago
targetedonc.com
PERSEUS and ELEVATE-TN Trials Are Potential Game-Changers in
…
Dec 13, 2023
targetedonc.com
See more videos
More like this
Feedback
Feedback